Source - SMW
Cantor Fitzgerald today initiates coverage of Mereo Biopharma Group Ltd (LON:MPH) with a buy investment rating and price target of 600p.

Related Charts

Mereo Biopharma Group (MPH)

0.00p (0.00%)
delayed 18:15PM